Attached files
| file | filename |
|---|---|
| EX-10.24 - EX-10.24 - ALDER BIOPHARMACEUTICALS INC | aldr-ex1024_649.htm |
| EX-32.1 - EX-32.1 - ALDER BIOPHARMACEUTICALS INC | aldr-ex321_8.htm |
| EX-31.2 - EX-31.2 - ALDER BIOPHARMACEUTICALS INC | aldr-ex312_9.htm |
| EX-31.1 - EX-31.1 - ALDER BIOPHARMACEUTICALS INC | aldr-ex311_6.htm |
| EX-10.25 - EX-10.25 - ALDER BIOPHARMACEUTICALS INC | aldr-ex1025_650.htm |
| EX-10.7 - EX-10.7 - ALDER BIOPHARMACEUTICALS INC | aldr-ex107_648.htm |
| 10-K - ALDR-10K-20161231 - ALDER BIOPHARMACEUTICALS INC | aldr-10k_20161231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S‑8 (Nos. 333-195807, 333-202738, and 333-209663) of Alder BioPharmaceuticals, Inc., of our report dated February 23, 2017 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Seattle, Washington
February 23, 2017